M3 (MTHRY) has a profit margin of 12.81%, below the Healthcare sector average of 19.13%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2026
Trailing 12 months ending Sep 2026
The latest profit margin for MTHRY is 12.81% as of September 2026. That compares with 14.91% in the prior-year period — down 14.1% year over year. That is below the Healthcare sector average of 19.13%. Investors often review this figure alongside M3's historical trend and sector peers before judging valuation or financial health.
Over the past year, MTHRY's profit margin moved from 14.91% to 12.81% — a 14.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in M3's valuation or profitability profile.
Against Healthcare companies, MTHRY currently prints 12.81% for profit margin, while the sector average sits near 19.13%. That is roughly 33.0% below the sector mean. Large gaps often invite a closer look at M3's growth, margins, and balance sheet.
Profit Margin shows how effectively M3 converts resources into returns. At 12.81%, MTHRY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 14.91% in the prior-year period — down 14.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting MTHRY's profit margin (12.81%), review year-over-year change from 14.91%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.